Literature DB >> 14745288

Lamivudine-induced acute pancreatitis in a patient with decompensated Hbv-related chronic liver disease.

Ali Riza Soylu, Gülbin Dökmeci, Ahmet Tezel, Bilge Cakir, Hasan Umit, Nesibe Karahan, Hümeyra Amuca.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 14745288     DOI： 10.1097/00004836-200402000-00010

Source DB:  PubMed          Journal:  J Clin Gastroenterol        ISSN： 0192-0790            Impact factor:   3.062


× No keyword cloud information.
  5 in total

1.  Cost-effectiveness analysis of prophylactic lamivudine use in preventing vertical transmission of hepatitis B virus infection.

Authors:  Hui-Fang Hung; Hsiu-Hsi Chen
Journal:  Pharmacoeconomics       Date:  2011-12       Impact factor: 4.981

2.  PAN's labyrinth: a multidisciplinary delayed diagnosis and patient's perspective.

Authors:  Emma Louise Barlow; Owen Seddon; Brendan Healy
Journal:  BMJ Case Rep       Date:  2016-01-05

Review 3.  Drug-induced pancreatitis : incidence, management and prevention.

Authors:  Anil R Balani; James H Grendell
Journal:  Drug Saf       Date:  2008       Impact factor: 5.606

Review 4.  Adverse effects of oral antiviral therapy in chronic hepatitis B.

Authors:  Bircan Kayaaslan; Rahmet Guner
Journal:  World J Hepatol       Date:  2017-02-18

5.  Drug induced pancreatitis: A systematic review of case reports to determine potential drug associations.

Authors:  Dianna Wolfe; Salmaan Kanji; Fatemeh Yazdi; Pauline Barbeau; Danielle Rice; Andrew Beck; Claire Butler; Leila Esmaeilisaraji; Becky Skidmore; David Moher; Brian Hutton
Journal:  PLoS One       Date:  2020-04-17       Impact factor: 3.240
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.